Carroll PR - Search Results

1

Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes.

Salciccia S, Capriotti AL, Laganà A, Fais S, Logozzi M, De Berardinis E, Busetto GM, Di Pierro GB, Ricciuti GP, Del Giudice F, Sciarra A, Carroll PR, Cooperberg MR, Sciarra B, Maggi M. Salciccia S, et al. Among authors: carroll pr. Int J Mol Sci. 2021 Apr 22;22(9):4367. doi: 10.3390/ijms22094367. Int J Mol Sci. 2021. PMID: 33922033 Free PMC article. Review.

2

Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer.

Roach M 3rd, Marquez C, Yuo HS, Narayan P, Coleman L, Nseyo UO, Navvab Z, Carroll PR. Roach M 3rd, et al. Among authors: carroll pr. Int J Radiat Oncol Biol Phys. 1994 Jan 1;28(1):33-7. doi: 10.1016/0360-3016(94)90138-4. Int J Radiat Oncol Biol Phys. 1994. PMID: 7505775 Review.

3

Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications.

Shinohara K, Wolf JS Jr, Narayan P, Carroll PR. Shinohara K, et al. Among authors: carroll pr. J Urol. 1994 Jul;152(1):120-3. doi: 10.1016/s0022-5347(17)32832-x. J Urol. 1994. PMID: 7515447

4

Screening for prostate cancer.

Cher ML, Carroll PR. Cher ML, et al. Among authors: carroll pr. West J Med. 1995 Mar;162(3):235-42. West J Med. 1995. PMID: 7536993 Free PMC article. Review.

5

Intermittent androgen deprivation: update of cycling characteristics in patients without clinically apparent metastatic prostate cancer.

Grossfeld GD, Chaudhary UB, Reese DM, Carroll PR, Small EJ. Grossfeld GD, et al. Among authors: carroll pr. Urology. 2001 Aug;58(2):240-5. doi: 10.1016/s0090-4295(01)01114-1. Urology. 2001. PMID: 11489710

6

Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor.

Cooperberg MR, Lubeck DP, Grossfeld GD, Mehta SS, Carroll PR. Cooperberg MR, et al. Among authors: carroll pr. J Urol. 2002 Aug;168(2):491-5. J Urol. 2002. PMID: 12131295

7

How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE.

Cooperberg MR, Koppie TM, Lubeck DP, Ye J, Grossfeld GD, Mehta SS, Carroll PR; CaPSURE. Cooperberg MR, et al. Among authors: carroll pr. Urology. 2003 Jan;61(1):190-6. doi: 10.1016/s0090-4295(02)02118-0. Urology. 2003. PMID: 12559294 Free article.

8

National practice patterns and time trends in androgen ablation for localized prostate cancer.

Cooperberg MR, Grossfeld GD, Lubeck DP, Carroll PR. Cooperberg MR, et al. Among authors: carroll pr. J Natl Cancer Inst. 2003 Jul 2;95(13):981-9. doi: 10.1093/jnci/95.13.981. J Natl Cancer Inst. 2003. PMID: 12837834 Free PMC article.

9

Cooperberg MR, Master VA, Carroll PR. Cooperberg MR, et al. Among authors: carroll pr. J Urol. 2003 Aug;170(2 Pt 1):512-5. doi: 10.1097/01.ju.0000074941.27370.c4. J Urol. 2003. PMID: 12853811

10

Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.

Harlan SR, Cooperberg MR, Elkin E, Lubeck DP, Meng M, Mehta SS, Carroll PR. Harlan SR, et al. Among authors: carroll pr. J Urol. 2003 Nov;170(5):1804-7. doi: 10.1097/01.ju.0000091641.34674.11. J Urol. 2003. PMID: 14532780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

816 results

Search Page